Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • N4-Acetylcytidine: Molecular Insights and Precision in RNA M

    2026-05-13

    N4-Acetylcytidine: Molecular Insights and Precision in RNA Modification Studies

    Introduction

    RNA modifications have emerged as critical regulators of genetic expression, with more than 160 distinct marks shaping RNA stability, processing, and translation. Among these, N4-Acetylcytidine (ac4C) stands out as a conserved and functionally diverse modification found in tRNA, rRNA, and mRNA across all domains of life. The recent surge in N4-Acetylcytidine research is driven by both its endogenous biological significance and its utility as a precision tool in RNA epigenetics research (source: paper).

    While several prior articles—such as "N4-Acetylcytidine: Biochemical Role and Research Benchmarks"—have focused on the compound’s benchmarking role and sourcing reliability, and others on structural aspects or troubleshooting workflows, this article provides a molecular-level synthesis: integrating structural mechanisms, solubility and storage considerations, and practical assay optimization, all anchored in the latest structural biology discoveries.

    Biochemical Properties and Handling of N4-Acetylcytidine

    N4-Acetylcytidine (C11H15N3O6, MW 285.25) is a chemically defined, acetylated cytidine distinguished by an acetyl group at the N4 position. This subtle modification dramatically alters its biochemical interactions, solubility, and stability:

    • Soluble to ≥52.6 mg/mL in DMSO and ≥5.24 mg/mL in water with ultrasonic assistance (source: product_spec).
    • Insoluble in ethanol (source: product_spec).
    • Shipped on blue/dry ice to ensure stability; storage at -20°C is critical for maintaining integrity (source: product_spec).
    • High purity (≈98%) verified by HPLC and NMR, meeting rigorous assay requirements (source: product_spec).

    These characteristics make it a reliable standard for post-transcriptional RNA modification workflows and for dissecting the function of acetylated cytidine in biological systems.

    Mechanistic Role in RNA Epigenetics and Nucleotide Processing

    The biological impact of ac4C is multi-faceted:

    • In tRNA, ac4C stabilizes base pairing and maintains translation fidelity, notably at the wobble position of elongator methionine tRNA (tRNAeMet), working in concert with lysidine modifications (source: paper).
    • In rRNA, ac4C in the stem regions of 18S rRNA and tRNASer/Leu enhances RNA duplex stability, facilitating proper processing and maturation (source: paper).
    • In mRNA, the modification’s position dictates its regulatory effect: ac4C in coding sequences promotes translation elongation, while in the 5′ UTR it inhibits initiation by impeding ribosome scanning (source: paper).

    These nuanced roles underscore why ac4C is essential for RNA structure-function analysis and for modeling the impact of RNA acetylation on gene expression and cell fate decisions.

    Reference Insight Extraction: Innovations from Structural Analysis

    The most transformative insight from Meng et al.'s study lies in their high-resolution structural characterization of the E. coli ASCH domain-containing enzyme EcYqfB. This enzyme catalyzes the hydrolysis of free ac4C nucleoside to cytidine, but—critically—does not act on RNA-incorporated ac4C (source: paper). This distinction clarifies prior ambiguities in ac4C metabolism:

    • EcYqfB’s exclusivity for free ac4C means that in biochemical assays, the presence of free N4-Acetylcytidine can be specifically manipulated or measured without confounding RNA degradation products.
    • Implications for assay design: Enzyme-based detection or removal systems should differentiate between free and RNA-bound ac4C, preventing erroneous interpretation of RNA processing results.
    • Comparative substrate specificity: Structural comparisons with homologs EOLA1 (mouse) and TRIP4-ASCH (human) reveal divergent substrate pockets, suggesting species-specific metabolic fates and offering a blueprint for designing selective inhibitors or probes for ac4C metabolism.

    This mechanistic clarity directly informs protocol optimization, as detailed below.

    Protocol Parameters

    • RNA modification enzyme assay | 10–100 μM ac4C | Compatible with yeast, bacterial, and mammalian RNA | Ensures sufficient concentration for enzyme-substrate interaction and detection | workflow_recommendation
    • Ac4C solution preparation | ≥52.6 mg/mL in DMSO; ≥5.24 mg/mL in water (ultrasonic assistance) | Enables both high-throughput and low-volume applications | Maximizes solubility and minimizes loss in diverse workflows | product_spec
    • Storage of modified nucleotide stock | -20°C | Maintains stability for extended periods | Prevents hydrolysis and degradation | product_spec
    • Purity control in functional assays | ≥98% purity (HPLC/NMR) | Required for reproducible RNA epigenetics research | Minimizes confounders in RNA modification quantification | product_spec

    Comparative Analysis: Beyond Structural Insight

    Previous cornerstone articles, such as "Structural Insights into ASCH Domain Proteins and N4-Acetylcytidine Processing", provided the first detailed look at EcYqfB’s structure and specificity. However, those works primarily dissect the enzyme’s physical attributes and evolutionary relationships. In contrast, this article translates those structural revelations into concrete guidance for experimental protocol design and troubleshooting, particularly in distinguishing free versus RNA-bound ac4C in complex biological mixtures.

    Similarly, "N4-Acetylcytidine in RNA Epigenetics: Workflows & Troubleshooting" offers workflow support and troubleshooting tips. Here, we synthesize these protocols with the new mechanistic understanding, providing a foundation for rational assay customization and control selection.

    Advanced Applications in RNA Epigenetics and Enzyme Assays

    The practical utility of high-purity N4-Acetylcytidine (C6648, APExBIO) is best realized in the following advanced applications:

    • RNA epigenetics research: Use as a spike-in standard for quantifying ac4C modifications by LC-MS/MS, ensuring accurate calibration and detection (source: product_spec).
    • Post-transcriptional RNA modification workflows: Benchmark modified cytidine incorporation into synthetic RNAs to validate the efficiency of acetyltransferase enzymes or to test the impact of ac4C on RNA folding and function (source: workflow_recommendation).
    • Nucleotide processing enzyme assays: Investigate the activity and specificity of candidate amidohydrolases, distinguishing between free and RNA-bound ac4C—now possible thanks to the structural insights into EcYqfB and its homologs (source: paper).
    • RNA structure-function analysis: Incorporate ac4C at defined positions in synthetic RNAs to dissect its effect on base pairing, stability, and protein binding, leveraging the compound’s well-characterized solubility and purity.

    This approach not only maximizes reproducibility but also enables new experimental designs to parse the functional consequences of RNA acetylation in health and disease.

    Assay Decision-Making: Integrating Structural and Biochemical Evidence

    The recent structural elucidation of ASCH domain proteins redefines how we approach nucleotide processing workflows. Knowing that only free ac4C is a substrate for EcYqfB-type amidohydrolases—and not RNA-incorporated ac4C—allows assay developers to:

    • Select the correct substrate form for enzymatic assays and avoid artifactual signals from RNA degradation products.
    • Design selective detection systems that discriminate between nucleotide pools and RNA-incorporated modifications.
    • Tailor inhibitor screens for ac4C-processing enzymes, informed by the unique substrate pockets revealed for EcYqfB, EOLA1, and TRIP4-ASCH (source: paper).

    By interlinking molecular structure, biochemical properties, and assay strategy, this framework advances beyond the more general discussions found in "N4-Acetylcytidine: Structural Insights and Precision in RNA Modification Studies", offering a more actionable roadmap for experimentalists.

    Conclusion and Outlook

    The convergence of high-purity chemical supply (APExBIO’s C6648), precise solubility and storage protocols, and newly clarified structural mechanisms has transformed N4-Acetylcytidine from a biochemical curiosity into a keystone for advanced RNA modification research. By leveraging the latest structural insights, researchers can now design more selective, reproducible assays—pushing the boundaries of RNA epigenetics and nucleotide metabolism studies. The next frontier lies in exploiting these mechanistic details for the rational development of selective probes and inhibitors, as well as in further dissecting species-specific pathways of ac4C metabolism (source: paper).

    For those seeking to implement or optimize RNA modification assays, N4-Acetylcytidine from APExBIO offers both the reliability and scientific grounding necessary for cutting-edge research.